Complete Coverage
The hospitalization rate and in-hospital mortality among patients with pulmonary arterial hypertension (PAH) seem to be stable in the US, according to a new study published in the journal Chest and presented at the Chest 2021 Annual Meeting. However, the proportion of diabetes among these patients seems to have decreased. Studies conducted before 2013 suggested…
Mechanically ventilated pulmonary arterial hypertension (PAH) patients have a worse outcome than similar patients without PAH, according to a study published in Chest and presented at the Chest 2021 Annual Meeting. The researchers also reported that the first 24 hours after intubation is a particularly vulnerable period that may be crucial for the long-term outcomes…
There may be an association between the MUC5B rs35705950 T allele and the risk of developing idiopathic pulmonary fibrosis (IPF), according to a new study published in the journal Chest and presented at the Chest 2021 Annual Meeting. Genetic screening could play a key role in a population whose members have a family history of IPF.…
There is an association between idiopathic pulmonary fibrosis (IPF) and gastroesophageal reflux disease (GERD), according to results published in Chest. The study is being presented virtually at the Chest 2021 Annual Meeting on Oct. 17-20, 2021. The association between IPF and GERD was already known possibly due to chronic micro-aspiration leading to lung parenchyma remodeling.…
Patients with idiopathic pulmonary fibrosis (IPF) who survived for 5 years or more had better lung function and quality of life compared to those who survived for less than 5 years, according to a study published in the Chest journal and being presented at the Chest 2021 Annual Meeting. They were also less likely to…
Changes in usual lung symptoms are not universally recognized as exacerbations, according to a new study published in the journal Chest and being presented at the Chest 2021 Annual Meeting. The correlation between symptom-based exacerbation and the definition of an exacerbation based on health care utilization is not high. Identifying pulmonary exacerbations in patients with…
A dedicated interstitial lung disease (ILD) clinic improves the care provided to patients with idiopathic pulmonary fibrosis (IPF), according to a recent study conducted by Gross et al. Improvements were observed even in clinics located in small healthcare systems, regardless of their association with a tertiary care center. The results of the study will be…
Are we testing enough for alpha-1 antitrypsin deficiency (AATD) in patients who develop chronic obstructive pulmonary disease (COPD)? Rao and colleagues set out to investigate the answer to this question. They discovered that only 20.6% of COPD patients underwent AATD testing, despite the majority of physicians demonstrating awareness of the importance to test all newly…
Intraductal papillary mucinous neoplasms (IPMNs) could increasingly be seen as a comorbidity in patients with pulmonary arterial hypertension (PAH), especially as their life expectancy increases. This is according to a new case study published in the Chest journal and being presented at the Chest 2021 Annual Meeting. More research is needed to see whether the…
Severe vitamin C deficiency is a rare cause of pulmonary arterial hypertension (PAH) that is easily treatable, according to a case study by Shrey Shah and colleagues published in Chest and being presented at the Chest 2021 Annual Meeting. It should, therefore, be considered in the appropriate clinical setting. The researchers presented the case of…
